RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,298,900 | +66859.5% | 1,819,132 | 0.0% | 0.81% | -23.2% |
| Q2 2023 | $22,848 | -36.0% | 1,819,132 | -16.1% | 1.06% | -39.6% |
| Q1 2023 | $35,726 | -99.9% | 2,169,132 | 0.0% | 1.76% | +2.8% |
| Q4 2022 | $32,406,832 | -33.2% | 2,169,132 | 0.0% | 1.71% | -37.4% |
| Q3 2022 | $48,523,000 | +8.5% | 2,169,132 | -18.7% | 2.73% | -3.6% |
| Q2 2022 | $44,708,000 | -44.0% | 2,669,132 | 0.0% | 2.83% | -31.0% |
| Q1 2022 | $79,887,000 | -2.5% | 2,669,132 | 0.0% | 4.11% | +29.0% |
| Q4 2021 | $81,969,000 | +100.9% | 2,669,132 | +106.2% | 3.18% | +123.4% |
| Q3 2021 | $40,804,000 | -13.8% | 1,294,132 | 0.0% | 1.42% | -14.7% |
| Q2 2021 | $47,352,000 | +5.8% | 1,294,132 | 0.0% | 1.67% | +10.2% |
| Q1 2021 | $44,738,000 | -16.8% | 1,294,132 | 0.0% | 1.52% | -12.3% |
| Q4 2020 | $53,784,000 | +0.9% | 1,294,132 | +3.4% | 1.73% | -6.2% |
| Q3 2020 | $53,321,000 | – | 1,251,959 | – | 1.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |